Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Pro- and Antiarrhythmic Actions of Sulfonylureas: Mechanistic and Clinical Evidence.

Leonard CE, Hennessy S, Han X, Siscovick DS, Flory JH, Deo R.

Trends Endocrinol Metab. 2017 Aug;28(8):561-586. doi: 10.1016/j.tem.2017.04.003. Epub 2017 May 22. Review.

PMID:
28545784
2.

Pancreatic regulation of glucose homeostasis.

Röder PV, Wu B, Liu Y, Han W.

Exp Mol Med. 2016 Mar 11;48:e219. doi: 10.1038/emm.2016.6. Review.

3.

Pharmacological rescue of trafficking-impaired ATP-sensitive potassium channels.

Martin GM, Chen PC, Devaraneni P, Shyng SL.

Front Physiol. 2013 Dec 24;4:386. doi: 10.3389/fphys.2013.00386. Review.

4.

Carbamazepine as a novel small molecule corrector of trafficking-impaired ATP-sensitive potassium channels identified in congenital hyperinsulinism.

Chen PC, Olson EM, Zhou Q, Kryukova Y, Sampson HM, Thomas DY, Shyng SL.

J Biol Chem. 2013 Jul 19;288(29):20942-54. doi: 10.1074/jbc.M113.470948. Epub 2013 Jun 6.

5.
6.

Diabetes treatment and cardiovascular safety.

Bloomgarden ZT.

Diabetes Care. 2011 Apr;34(4):e36-42. doi: 10.2337/dc11-0201. No abstract available.

7.

Cardiovascular safety of exenatide BID: an integrated analysis from controlled clinical trials in participants with type 2 diabetes.

Ratner R, Han J, Nicewarner D, Yushmanova I, Hoogwerf BJ, Shen L.

Cardiovasc Diabetol. 2011 Mar 16;10:22. doi: 10.1186/1475-2840-10-22.

8.

Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injury.

Lefer DJ, Nichols CG, Coetzee WA.

Trends Cardiovasc Med. 2009 Feb;19(2):61-7. doi: 10.1016/j.tcm.2009.04.008. Review.

9.

Effect of second-generation sulfonylureas on survival in patients with diabetes mellitus after myocardial infarction.

Arruda-Olson AM, Patch RK 3rd, Leibson CL, Vella A, Frye RL, Weston SA, Killian JM, Roger VL.

Mayo Clin Proc. 2009;84(1):28-33. doi: 10.1016/S0025-6196(11)60804-5.

10.

Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.

Simpson SH, Majumdar SR, Tsuyuki RT, Eurich DT, Johnson JA.

CMAJ. 2006 Jan 17;174(2):169-74.

Supplemental Content

Support Center